View in EDS

Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib.

Saved in:
Bibliographic Details
Title: Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib.
Authors: Horinouchi, H.1 (AUTHOR), Cho, B.C.2 (AUTHOR), Camidge, D.R.3 (AUTHOR), Goto, K.4 (AUTHOR), Tomasini, P.5 (AUTHOR), Li, Y.6 (AUTHOR), Vasilopoulos, A.6 (AUTHOR), Brunsdon, P.6 (AUTHOR), Hoffman, D.6 (AUTHOR), Shi, W.6 (AUTHOR), Bolotin, E.6 (AUTHOR), Blot, V.6 (AUTHOR), Goldman, J.1,7 (AUTHOR)
Source: Annals of Oncology. May2025, Vol. 36 Issue 5, p583-591. 9p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 184711723
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Horinouchi%2C+H%2E%22">Horinouchi, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cho%2C+B%2EC%2E%22">Cho, B.C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Camidge%2C+D%2ER%2E%22">Camidge, D.R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goto%2C+K%2E%22">Goto, K.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tomasini%2C+P%2E%22">Tomasini, P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Y%2E%22">Li, Y.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vasilopoulos%2C+A%2E%22">Vasilopoulos, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brunsdon%2C+P%2E%22">Brunsdon, P.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoffman%2C+D%2E%22">Hoffman, D.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+W%2E%22">Shi, W.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bolotin%2C+E%2E%22">Bolotin, E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blot%2C+V%2E%22">Blot, V.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goldman%2C+J%2E%22">Goldman, J.</searchLink><relatesTo>1,7</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. May2025, Vol. 36 Issue 5, p583-591. 9p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=184711723
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.01.001
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 583
    Titles:
      – TitleFull: Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Horinouchi, H.
      – PersonEntity:
          Name:
            NameFull: Cho, B.C.
      – PersonEntity:
          Name:
            NameFull: Camidge, D.R.
      – PersonEntity:
          Name:
            NameFull: Goto, K.
      – PersonEntity:
          Name:
            NameFull: Tomasini, P.
      – PersonEntity:
          Name:
            NameFull: Li, Y.
      – PersonEntity:
          Name:
            NameFull: Vasilopoulos, A.
      – PersonEntity:
          Name:
            NameFull: Brunsdon, P.
      – PersonEntity:
          Name:
            NameFull: Hoffman, D.
      – PersonEntity:
          Name:
            NameFull: Shi, W.
      – PersonEntity:
          Name:
            NameFull: Bolotin, E.
      – PersonEntity:
          Name:
            NameFull: Blot, V.
      – PersonEntity:
          Name:
            NameFull: Goldman, J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1